Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antibacterial combination therapy]

C Tauchnitz

    Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
    |July 15, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Antibacterial drug combinations can enhance effectiveness and slow resistance. Clinically useful synergy often involves aminoglycosides combined with other antibiotic classes, but antagonistic combinations should be avoided.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy].

    Medizinische Monatsschrift fur Pharmazeuten·2002
    Same author

    [Treatment with antibacterial chemotherapy].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·1992
    Same author

    [Current status and change in infectiology].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·1992
    Same author

    [Diagnosis and therapy of urinary tract infections].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·1992
    Same author

    [Effective microbiologic spectrum of gyrase inhibitors--indications and contraindications].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·1990
    Same author

    [Comment on the contribution by H. Lode and R. Schröder: "Possibilities for errors in endocarditis therapy"].

    Der Internist·1990
    Same journal

    [Report on the Fifth International Congress on Blood Transfusion, Paris, 13 to 19 September 1954].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·2014
    Same journal

    [Blood coagulation; literature from 1952 to 1954. VI].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·2014
    Same journal

    [Blood coagulation; publications from 1952-1954. V].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·2014
    Same journal

    [Blood coagulation from 1952-1954. IV].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·2014
    Same journal

    [Report on the fourth congress of the European Gastroenterological Society in Paris, 27 June to 2 July 1954].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·2014
    Same journal

    [The islands of Langerhans in pancreatic carcinoma].

    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete·2014
    See all related articles

    Area of Science:

    • Microbiology
    • Pharmacology
    • Infectious Diseases

    Context:

    • Antibacterial drug combinations are frequently prescribed to enhance therapeutic outcomes and mitigate the emergence of antimicrobial resistance.
    • In vitro studies provide evidence for specific antibiotic pairings that exhibit synergistic or antagonistic effects.

    Purpose:

    • To review the rationale and evidence supporting the use of antibacterial combinations.
    • To identify antibiotic pairings that demonstrate clinical synergy and those that should be avoided.

    Summary:

    • Synergistic antibacterial effects and delayed resistance development are key reasons for using combination therapy.
    • Clinically useful synergy is often achieved by combining aminoglycosides with penicillins, cephalosporins, polymyxins, or bacteriostatic agents (e.g., tetracyclines, macrolides, lincomycin).

    Related Experiment Videos

  • The effectiveness of combinations, measured by minimum bactericidal concentration (MBC) and minimum inhibitory concentration (MIC) values, varies by bacterial species and strain.

    • Impact:

    • Combination therapy with demonstrated antibacterial synergism is crucial for treating life-threatening infections and eradicating persistent bacterial populations.
    • Avoiding combinations with antagonistic effects is essential to prevent treatment failure.
    • The indiscriminate use of multiple antibiotics solely for broader spectrum coverage is not supported by current evidence.